SCHEMBL1974170

SCHEMBL1974170

O[SiH][SiH3]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17519118 0.67
SCHEMBL4520004 0.61
SCHEMBL9901675 0.61
SCHEMBL356086 0.61
SCHEMBL6519554 0.55
SCHEMBL6519556 0.55
Ethylene SCHEMBL9212488 0.55
Ethylene SCHEMBL7624355 0.55
SCHEMBL2039479 0.50
SCHEMBL490942 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103298853-B Reactive functional group-modified molecularly self-assembling material DOW GLOBAL TECHNOLOGIES INC 2015-06-24 CN disclosed
US-8697375-B2 In vivo biofilm infection diagnosis and treatment UNIVERSITY OF MARYLAND, BALTIMORE (US) 2014-04-15 US disclosed
CN-103298853-A Reactive functional group-modified molecularly self-assembling material DOW GLOBAL TECHNOLOGIES INC 2013-09-11 CN disclosed
US-20110171123-A1 In Vivo Biofilm Infection Diagnosis and Treatment UNIVERSITY OF MARYLAND, BALTIMORE (US) 2011-07-14 US disclosed
EP-2335073-A2 IN VIVO BIOFILM INFECTION DIAGNOSIS AND TREATMENT University of Maryland Baltimore (US) 2011-06-22 EP disclosed
WO-2010028013-A2 IN VIVO BIOFILM INFECTION DIAGNOSIS AND TREATMENT UNIVERSITY OF MARYLAND, BALTIMORE (US) 2010-03-11 WO disclosed